2026 Taiwan society of lipids and atherosclerosis consensus statement for the identification and management of patients receiving suboptimally tolerable statins
{{output}}
Statins are the cornerstone of lipid-lowering therapy for the prevention of atherosclerotic cardiovascular disease (ASCVD); however, many patients are unable to achieve guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets because of subopt... ...
